Investors sentiment increased to 1.19 in Q4 2018. Its up 0.04, from 1.15 in 2018Q3. It improved, as 34 investors sold PetMed Express, Inc. shares while 40 reduced holdings. 38 funds opened positions while 50 raised stakes. 20.00 million shares or 10.50% more from 18.10 million shares in 2018Q3 were reported.
Zurcher Kantonalbank (Zurich Cantonalbank) reported 0% stake. Endurant Cap Mgmt L P invested in 67,010 shares or 0.82% of the stock. Ameritas Invest Prns Inc accumulated 1,778 shares. Voya Investment Mngmt Limited Liability reported 32,528 shares. D E Shaw And, New York-based fund reported 101,227 shares. State Of Alaska Department Of Revenue reported 6,908 shares. Envestnet Asset Mngmt Inc invested 0% of its portfolio in PetMed Express, Inc. (NASDAQ:PETS). Newtyn Mgmt Limited Liability Company invested in 150,000 shares. Peoples Fincl holds 0.01% or 1,000 shares. Tudor Invest Et Al reported 34,115 shares. Comerica National Bank & Trust holds 23,105 shares. American Century Inc holds 0.01% of its portfolio in PetMed Express, Inc. (NASDAQ:PETS) for 261,740 shares. Group One Trading Ltd Partnership reported 7,296 shares. Sg Americas Secs Limited Co holds 61,256 shares or 0.01% of its portfolio. Chicago Equity Prtnrs Ltd Co has invested 0.02% of its portfolio in PetMed Express, Inc. (NASDAQ:PETS).
The stock of Petmed Express Inc (NASDAQ:PETS) registered a decrease of 6.65% in short interest. PETS’s total short interest was 8.64M shares in March as published by FINRA. Its down 6.65% from 9.25M shares, reported previously. With 448,300 shares average volume, it will take short sellers 19 days to cover their PETS’s short positions. The short interest to Petmed Express Inc’s float is 48.15%.
The stock increased 4.25% or $0.88 during the last trading session, reaching $21.59. About 662,188 shares traded or 0.62% up from the average. PetMed Express, Inc. (NASDAQ:PETS) has declined 50.36% since March 25, 2018 and is downtrending. It has underperformed by 54.73% the S&P500.
PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company has market cap of $442.23 million. The firm markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats to retail customers. It has a 10.74 P/E ratio. It provides non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, thyroid, diabetes, pain medications, antibiotics, and other specialty medications, as well as generic substitutes.
More notable recent PetMed Express, Inc. (NASDAQ:PETS) news were published by: Forbes.com which released: “Small Caps And Big Tech Dominate The Nasdaq, And These 5 Stocks Are Especially Interesting – Forbes” on March 18, 2019, also Globenewswire.com with their article: “CBD Is Going to The Dogs: Continued Growth in Hemp Derived Pet Products – GlobeNewswire” published on March 04, 2019, Nasdaq.com published: “Breakfast from the Backyard: Home Poultry Ownership Fosters Closer Connection to our Food – Nasdaq” on February 25, 2019. More interesting news about PetMed Express, Inc. (NASDAQ:PETS) were released by: Nasdaq.com and their article: “OurPet’s Company Signs Merger Agreement with Hyper Pet LLC – Nasdaq” published on December 19, 2018 as well as Nasdaq.com‘s news article titled: “Better Choice Company Announces Launch of 9 New CBD Product SKUs – Nasdaq” with publication date: March 12, 2019.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.